SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.

Shanghai MicroPort Endovascular MedTech Co., Ltd.

688016

CNE100003MJ5

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-22 pm EDT			5-day change	1st Jan Change
175.5 ^CNY	+1.86%		+3.45%	-9.83%

Feb. 23	Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 30	MicroPort Scientific Unit to See Up to 38% Boost in 2023 Profit	MT

Shanghai MicroPort Endovascular MedTech Co., Ltd. Announces Earnings Results for the Nine Months of 2019

October 26, 2019

Shanghai MicroPort Endovascular MedTech Co., Ltd. announced earnings results for the nine months of 2019. For the period, the company reported basic earnings per share of CNY 1.94.

Latest news about Shanghai MicroPort Endovascular MedTech Co., Ltd.

Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
MicroPort Scientific Unit to See Up to 38% Boost in 2023 Profit	Jan. 30	MT
Shanghai MicroPort Endovascular MedTech Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2023	Jan. 29	CI
EV MedTech Raises 1.8 Billion Yuan from Placement	Dec. 14	MT
MicroPort Endovascular MedTech Elects Chairman	Nov. 24	MT
Shanghai MicroPort Endovascular MedTech's Profit Up 29% in Q1-Q3	23-10-30	MT
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Shanghai MicroPort Endovascular MedTech's H1 Attributable Profit Increases 30%	23-08-28	MT
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-28	CI
Shanghai Bourse Approves EV MedTech's Proposed Share Issuance	23-07-13	MT
EV MedTech Expects Up to 30% Increase in First-Half Profit	23-07-11	MT
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Shanghai MicroPort Endovascular MedTech Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2022	23-01-20	CI
Shanghai Hongmai Medical Technology Co., Ltd. announced that it expects to receive CNY 45 million in funding from Shanghai MicroPort Endovascular MedTech Co., Ltd., Shanghai Xiying Enterprise Consulting Partnership (Limited Partnership)	22-12-13	CI
Shanghai MicroPort Endovascular MedTech Co., Ltd.(SHSE:688016) dropped from Shanghai Stock Exchange Health Care Sector Index	22-12-09	CI
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Shanghai MicroPort Endovascular MedTech Sees Q3 Profit Jump 31.5%	22-10-24	MT
Shanghai MicroPort Endovascular MedTech Co., Ltd.(XSSC:688016) added to S&P Global BMI Index	22-09-19	CI
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
MicroPort Scientific Unit to Issue A Shares	22-07-25	MT
Shanghai MicroPort Endovascular MedTech Co., Ltd. announced that it expects to receive CNY 2.5468393 billion in funding	22-07-24	CI
Certain A Shares of Shanghai MicroPort Endovascular MedTech Co., Ltd. are subject to a Lock-Up Agreement Ending on 22-JUL-2022.	22-07-21	CI
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
UBS Adjusts Shanghai MicroPort Endovascular MedTech's Price Target to 250 Yuan From 239 Yuan, Keeps at Buy	22-03-31	MT

Chart Shanghai MicroPort Endovascular MedTech Co., Ltd.

Duration

Period

Chart Shanghai MicroPort Endovascular MedTech Co., Ltd.

More charts

Shanghai MicroPort Endovascular MedTech Group Co Ltd, formerly Shanghai MicroPort Endovascular MedTech Co Ltd, is a China-based company principally engaged in the research and development, production and sales of aortic and peripheral vascular interventional medical devices. The Company's main products include the aortic stent graft system for aortic minimally invasive interventional procedures, the intraoperative stent system for open surgery, as well as the peripheral vascular stent system and peripheral balloon dilatation catheters for the treatment of peripheral vascular diseases. The Company mainly distributes its products to the domestic market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-04-26 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Shanghai MicroPort Endovascular MedTech Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

175.5 CNY

Average target price

237.4 CNY

Spread / Average Target

+35.26%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-9.83%	2B
STRYKER CORPORATION	+11.84%	127B
SMITH & NEPHEW PLC	-8.69%	10.68B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-1.71%	8.59B
INSPIRE MEDICAL SYSTEMS, INC.	+14.99%	7.09B
GLAUKOS CORPORATION	+27.16%	5.07B
AXONICS, INC.	+6.81%	3.39B
ENOVIS CORPORATION	-0.98%	3.04B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-13.77%	2.02B
DOUBLE MEDICAL TECHNOLOGY INC.	-27.30%	1.69B

Medical Devices & Implants